Remote Jobs at Erasca, Inc.

Erasca, Inc.

51 - 200 employees

Founded 2020

🧬 Biotechnology

💊 Pharmaceuticals

🔬 Science

💰 $100M Post-IPO Equity on 2022-12

Biotechnology • Pharmaceuticals • Science

Erasca, Inc. is a clinical-stage precision oncology company committed to eradicating cancer by targeting one of cancer's most commonly mutated pathways, the RAS/MAPK pathway. The company is dedicated to developing a modality-agnostic portfolio of therapeutic programs designed to thoroughly shut down the RAS/MAPK pathway, which affects millions of lives globally each year. Erasca is advancing a robust pipeline with the potential to transform cancer treatment and improve the lives of patients suffering from various types of cancer. With a focus on groundbreaking science in oncology, Erasca aims to bring new hope to patients and lead the way in precision oncology innovations.